文献速递复苏、休克与脓毒症创伤与烧伤

新型部分性复苏性主动脉腔内球囊阻断装置可在1区部署超过2小时且几乎无需操作者滴定

A novel partial resuscitative endovascular balloon aortic occlusion device that can be deployed in zone 1 for more than 2 hours with minimal provider titration.
PubMed 文献 · J Trauma Acute Care Surg · 2021-01-01
一句话结论猪出血性休克模型中,新型pREBOA-PRO在1区部分阻断2小时无需频繁滴定,远端缺血与再灌注损伤轻于完全阻断,升压效果相当。

研究为动物实验:10头雌性约克夏猪经40%失血性休克1小时(MAP 28–32 mm Hg)后随机接受完全性主动脉阻断(ER-REBOA)或新型部分性阻断(pREBOA-PRO),后者以远端波形迹出现判定部分阻断、不设远端MAP目标、不做频繁滴定。1区阻断2小时后回输失血、50%自体输血后10分钟内逐步放气,再复苏观察2小时。部分阻断组实验终点乳酸(p=0.006)、LDH(p=0.0004)、AST(p=0.004)更低,去甲肾上腺素(p=0.002)、碳酸氢钠(p=0.006)及液体复苏(p=0.042)用量更少,近端MAP升高幅度相似。提示改进设计的pREBOA可延长1区部署时间并减轻远端缺血与再灌注损伤。

要点

  • 在40%失血性休克猪模型中,pREBOA-PRO于1区部分阻断2小时无需频繁操作者滴定或远端MAP目标,近端MAP升高与完全阻断相似。
  • 部分阻断组实验终点血清乳酸(p=0.006)、LDH(p=0.0004)、AST(p=0.004)均低于完全阻断组,提示远端缺血与再灌注损伤更轻。
  • 部分阻断组去甲肾上腺素(p=0.002)、碳酸氢钠(p=0.006)及液体复苏(p=0.042)用量均少于完全阻断组。
  • 部分阻断以检测到远端波形迹(trace distal waveform)判定,而非按远端MAP目标滴定。
  • 所有动物均存活至实验结束;该结论来自小样本(N=10)动物实验,尚未在人体验证。

适用人群与场景

  • 雌性约克夏猪(N=10),经历40%失血性休克1小时、MAP 28–32 mm Hg的动物模型;非人体研究,原文未给出人体适用人群。

诊断标准与关键阈值

  • 失血性休克模型标准:40%失血性休克持续1小时,MAP维持在28–32 mm Hg。
  • pREBOA-PRO部分阻断判定:检测到远端波形迹(trace distal waveform),不设远端MAP目标。
  • 复苏目标:CVP≥6 mm Hg(乳酸林格液bolus)、MAP 55–60 mm Hg(去甲肾上腺素 infusion)、pH>7.2(酸硷纠正)。

处置流程与药物剂量

  • 第一步:建立40%失血性休克1小时(MAP 28–32 mm Hg)模型后随机分组。
  • 第二步:pREBOA-PRO组在1区部署球囊,以检测到远端波形迹判定部分阻断,不做频繁滴定、不设远端MAP目标;ER-REBOA组行完全性主动脉阻断。
  • 第三步:1区阻断持续2小时。
  • 第四步:回输失血的全面血;50%自体输血后,球囊在10分钟内逐步放气。
  • 第五步:输血后继续复苏并观察2小时:乳酸林格液bolus目标CVP≥6 mm Hg,去甲肾上腺素 infusion目标MAP 55–60 mm Hg,酸硷纠正目标pH>7.2。

红旗征与不能漏的情况

  • 原文未提及

研究设计与关键结果

  • 研究类型:随机对照动物实验;样本量N=10头雌性约克夏猪;单中心(原文未写明中心数)。
  • 干预与对照:pREBOA-PRO部分阻断 vs ER-REBOA完全阻断,1区阻断2小时,均不设远端MAP目标。
  • 主要终点结果:所有动物均存活至实验结束;两组近端MAP升高相似,部分阻断组远端MAP略高。
  • 关键次要终点:部分阻断组实验终点乳酸(p=0.006)、LDH(p=0.0004)、AST(p=0.004)更低;去甲肾上腺素(p=0.002)、碳酸氢钠(p=0.006)、液体复苏(p=0.042)用量更少。
  • 不良事件:原文未提及具体不良事件。

证据类型、等级与局限

  • 证据类型:随机对照动物实验(猪模型)。
  • 证据等级或推荐强度:原文未提及。
  • 局限:样本量小(N=10)、动物模型、单中心(原文未写明中心数)、结果尚未在人体验证;原文未提及盲法与分配隐藏。

对床旁实践的改变

  • 该动物实验提示:改进设计的pREBOA-PRO可在1区部分阻断2小时且无需频繁操作者滴定,并减轻远端缺血与再灌注损伤、减少升压药与液体需求;但尚不能直接改变人体急诊/ICU实践,需人体研究验证。
  • 原文的复苏目标(CVP≥6 mm Hg、MAP 55–60 mm Hg、pH>7.2)为动物实验方案,不应直接作为人体通用推荐。
  • 常见陷阱:将动物实验中的部分阻断判定方式(远端波形迹)和2小时阻断时长直接外推至人体;原文未提供人体剂量、阈值或适用人群。

指南或共识出处

  • 原文未提及指南或共识;来源期刊:J Trauma Acute Care Surg。

以上提炼依据论文摘要(全文未开放获取,或许可不允许翻译转载);全文请点「阅读原文」。

英文原文(摘要)· 点击展开

BACKGROUND: Hemorrhage is a leading cause of mortality in trauma. Resuscitative endovascular balloon occlusion of the aorta (REBOA) can control hemorrhage, but distal ischemia, subsequent reperfusion injury, and the need for frequent balloon titration remain problems. Improved device design can allow for partial REBOA (pREBOA) that may provide hemorrhage control while also perfusing distally without need for significant provider titration.

METHODS: Female Yorkshire swine (N = 10) were subjected to 40% hemorrhagic shock for 1 hour (mean arterial pressure [MAP], 28-32 mm Hg). Animals were then randomized to either complete aortic occlusion (ER-REBOA) or partial occlusion (novel pREBOA-PRO) without frequent provider titration or distal MAP targets. Detection of a trace distal waveform determined partial occlusion in the pREBOA-PRO arm. After 2 hours of zone 1 occlusion, the hemorrhaged whole blood was returned. After 50% autotransfusion, the balloon was deflated over a 10-minute period. Following transfusion, the animals were survived for 2 hours while receiving resuscitation based on objective targets: lactated Ringer's fluid boluses (goal central venous pressure, ≥ 6 mm Hg), a norepinephrine infusion (goal MAP, 55-60 mm Hg), and acid-base correction (goal pH, >7.2). Hemodynamic variables, arterial lactate, lactate dehydrogenase, aspartate aminotransferase, and creatinine levels were measured.

RESULTS: All animals survived throughout the experiment, with similar increase in proximal MAPs in both groups. Animals that underwent partial occlusion had slightly higher distal MAPs. At the end of the experiment, the partial occlusion group had lower end levels of serum lactate (p = 0.006), lactate dehydrogenase (p = 0.0004) and aspartate aminotransferase (p = 0.004). Animals that underwent partial occlusion required less norepinephrine (p = 0.002), less bicarbonate administration (p = 0.006), and less fluid resuscitation (p = 0.042).

CONCLUSION: Improved design for pREBOA can decrease the degree of distal ischemia and reperfusion injury compared with complete aortic occlusion, while providing a similar increase in proximal MAPs. This can allow pREBOA zone-1 deployment for longer periods without the need for significant balloon titration.

来源:J Trauma Acute Care Surg,查看原文。版权归原作者所有。

参考来源

  1. Kemp MT, Wakam GK, Williams AM, et al. A novel partial resuscitative endovascular balloon aortic occlusion device that can be deployed in zone 1 for more than 2 hours with minimal provider titration. J Trauma Acute Care Surg. 2021. PMID: 33492106. doi:10.1097/TA.0000000000003042

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。